Ambu saw the highest growth of 0.7% in patent filings in April and 1.39% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.7% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Ambu’s patent filings and grants. Buy the databook here.
Ambu has been focused on protecting inventions in European Patent Office(EPO) with 21 publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 58% filings and 38% grants. The European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where Ambu is filings its patents. Among the top granted patent authorities, Ambu has 62% of its grants in United States(US) and 38% in European Patent Office(EPO).
Olympus and Fujifilm could be the strongest competitors for Ambu
Ambu stands in second position with respect to its patent publications among its competitors.
Patents related to healthtech and smart hospitals lead Ambu's portfolio
Ambu has the highest number of patents in healthtech followed by, smart hospitals and smart materials. For healthtech, nearly 62% of patents were filed and 23% of patents were granted in Q2 2024.
Diagnostic imaging related patents lead Ambu portfolio followed by consumer applications, and other remote patient monitoring
Ambu has highest number of patents in diagnostic imaging followed by consumer applications, other remote patient monitoring, image management, and medical device.
For comprehensive analysis of Ambu's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.